A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin
Clinical trial NCT05357911 · COMPLETED
Trial details
- NCT number
- NCT05357911
- Sponsor
- Nuvation Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-13
- Primary completion
- 2021-08-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.